Increase/Decrease in Cash: The total change in cash for the company over the given period.
ASLAN Pharmaceuticals Ltd. (ASLN) had Increase/Decrease in Cash of $-35.65M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$12.00M |
|
$-44.22M |
|
-- |
|
$12.00M |
|
$55.74M |
|
$-43.74M |
|
$-0.35M |
|
$-44.09M |
|
$-44.09M |
|
$-44.22M |
|
$-44.22M |
|
$-44.22M |
|
$-44.22M |
|
$-43.74M |
|
$-43.39M |
|
16.45M |
|
16.45M |
|
$-2.69 |
|
$-2.69 |
|
| Balance Sheet Financials | |
$24.13M |
|
$0.03M |
|
$0.50M |
|
$24.63M |
|
$13.11M |
|
$24.80M |
|
$24.80M |
|
$37.91M |
|
$-13.29M |
|
$-13.29M |
|
$-13.29M |
|
17.60M |
|
| Cash Flow Statement Financials | |
$-46.64M |
|
$0.27M |
|
$10.72M |
|
$56.90M |
|
$21.25M |
|
|
Increase/Decrease in Cash |
$-35.65M |
$2.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.84 |
|
-- |
|
-- |
|
2.15 |
|
-2.00 |
|
100.00% |
|
-364.46% |
|
-364.46% |
|
-361.56% |
|
-367.39% |
|
-368.50% |
|
$-46.65M |
|
-- |
|
-- |
|
-- |
|
0.49 |
|
-- |
|
-- |
|
-- |
|
332.81% |
|
332.76% |
|
-179.56% |
|
-384.13% |
|
$-0.76 |
|
$-2.84 |
|
$-2.84 |
|